Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects (SAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03262909
Recruitment Status : Active, not recruiting
First Posted : August 25, 2017
Last Update Posted : March 22, 2022
Information provided by (Responsible Party):
Regentis Biomaterials